Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : STEM -- StemCells, Inc. -- Ignore unavailable to you. Want to Upgrade?

To: WWS who wrote (215)	2/25/1999 6:55:00 AM
From: Mike McFarland	Read Replies (1) \| Respond to of 805

...shepherd this development through to completion? There was some speculation of a partner on the yahoo thread not long ago...it was also posted here...go to post 207. In the meantime, you have to hope the Astra pain trials go well... Astra restarted the European Phase II clinical trial of the pain control implant in June following the successful redesign of the implant surgical procedure. Astra expects patient enrollment for the current trial to be completed shortly; efficacy data is expected around mid-year. They have 17M with a burn of 650M/mo...book value $1.3/share so I have no problem owning this at these prices.